cannabis practice group

overview representative matters publications & presentations

McMillan’s leading Cannabis Practice Group provides innovative and practical solutions to clients in the cannabis industry.

The cannabis industry is quickly evolving in Canada, amid a complex and rapidly changing regulatory scheme, and McMillan is at the leading edge of these developments. McMillan’s Cannabis Practice Group, one of the largest groups of its kind in Canada, works closely with a wide range of industry participants, including licensed producers, retailers, investors, technology and other service providers, to help them succeed in the medical cannabis industry. Our group is made up of experienced professionals with significant in-depth knowledge. We understand the laws, regulations and business landscape of Canada’s medical cannabis industry, and can provide you with valuable legal solutions for financing, accessing public markets, licensing and regulation, employment law and workplace issues, mergers and acquisitions, tax structuring and intellectual property matters, whether you are just entering the market or already established.

We help our clients lead by:

structuring financing arrangements through private equity, public markets, and venture capital,
navigating the complex medical marijuana regulatory system, assisting with regulatory approvals,
advising on mergers, acquisitions and divestitures,
assisting with labeling, advertising and distribution matters,
drafting comprehensive employment agreements and workplace policies in compliance with applicable laws,
advising on tax matters, and
assisting with patents, trademarks, licensing, outsourcing and strategic alliances

• Aurora Cannabis in its US$852 million (or CAD $1.1 billion) acquisition of CanniMed Therapeutics Inc.
• Counsel for Aurora Cannabis Inc. in connection with a $15 million convertible debenture offering
• Counsel for Aurora Cannabis Inc. in connection with a $23 million convertible debenture offering
• Counsel for Aurora Cannabis Inc. in connection with a $60 million bought deal private placement
• Counsel for Aurora Cannabis Inc. in connection with a $75 million bought deal private placement of units
• Counsel for Aurora Cannabis Inc. in connection with a $200 million bought deal private placement of debentures
• Counsel for Aurora Cannabis Inc. in connection with its acquisition of Pedanios GmbH, a wholesale importer, exporter, and distributor of medical cannabis in the European Union
• Counsel for Aurora Cannabis Inc. in connection with its investment in Cann Group, an Australian Licensed Provider
• Counsel for Aurora Cannabis Inc. in its acquisition of a 25% stake in Liquor Stores N.A. Ltd. valued at $140 million
• Counsel for Canaccord Genuity in connection with the financing for Astar Minerals Ltd.
• Counsel for Cannex Capital Group Inc. in connection with its $36 million acquisition of BrightLeaf Development LLC (BLD)
• Counsel for Cannex Capital Group Inc. in connection with its $48.2 million subscription receipt offering
• Counsel for Counsel for various capital pool companies (TSX-V) in connection with a qualifying transaction and associated financings
• Counsel for Emblem Corp. in connection with its qualifying transaction by way of a three-cornered amalgamation to become a public medical marijuana producer
• Counsel for Green Organic Dutchman in the $132 million financing and strategic Investment of $55 million by Aurora Cannabis Inc.
• Counsel for Harvest One Cannabis Inc. in its acquisition of United Greeneries Holdings Ltd. from and Satipharm AG ‘s from MMJ PhytoTech Limited
• Counsel for Harvest One Capital Inc. in connection with a $25 million private placement
• Counsel for Harvest One Capital Inc. in connection with the ~$50 million acquisition (inclusive of acquisition cost and retirement of debt) of a licensed medical marijuana producer and a Swiss medical marijuana related health products company
• Counsel for High Hampton Holdings Corp. in its $19 million nonbrokered reverse takeover private placement
• Counsel for iAnthus Capital Holdings Inc. in connection with a $20 million bought deal private placement of 8% unsecured convertible debentures
• Counsel for iAnthus Capital Holdings Inc. in connection with a $20 million bought deal short form prospectus and concurrent $1.5 million non-brokered private placement. The financing was the first bought deal offering to be completed on the Canadian Securities Exchange
• Counsel for iAnthus Capital Holdings Inc. in connection with a $5.8 million asset acquisition
• Counsel for iAnthus Capital Holdings Inc. in connection with a $50 million financing ($40 million debt and US$10 million equity).
• Counsel for Lifestyle Delivery Systems Inc. in connection with a reverse takeover of Canna Delivery Systems Inc.
• Counsel for OrganiGram Holdings Inc. in connection with a $10.4 million bought deal short form prospectus financing
• Counsel for OrganiGram Holdings Inc. in connection with a $23 million bought deal short form prospectus financing
• Counsel for OrganiGram Holdings Inc. in connection with a $29.3 million reverse take-over transaction financing
• Counsel for OrganiGram Holdings Inc. in connection with a $40.3 million bought deal short form prospectus financing
• Counsel for Body and Mind Inc. in connection with its reverse takeover and listing
• Counsel for Saber Capital Corp. in connection with a $2 million short form offering document in connection with a $21.6 million brokered and non-brokered offering and $2 million short form offering
• Counsel for Saber Capital Corp. in connection with a qualifying transaction and concurrent $21.6 million financing with Emblem Corp.
• Counsel for Sante Veritas Therapeutics Inc. in connection with a nonbrokered private placement of shares placed through
Canaccord Genuity Corp. and PowerOne Capital Markets Limited with gross proceeds of $6.6 million
• Counsel for THC Meds Inc. and THC Medical Systems Ltd. in a reverse takeover of Thelon Capital Ltd.
• Counsel for The Green Organic Dutchman (TSE:TGOD) in its$132 million IPO